"colorectal cancer; inflammation; tumor"@en . "The recurrence of a cancer - local or distant (metastasis) - is manifested by the persistence of cancer cells in the organism after the ablation of the primary lesion, an ineffective anticancer immune response, and by the activity of biological/immunological factors that can stimulate and sustain its development. This review focuses on colorectal carcinoma and discusses some aspects of cancer immunology regarding cancer development and its recurrence. It is addressed also to the clinician to provide new insights helpful for designing better therapeutic strategies and patient's follow up. Therapeutic approaches used during and after surgical treatments, found capable of modulating immunity (differently affecting disease outcome), will also be described"@en . . . . . . "Frontiers in Bioscience (Scholar Edition)" . "Cancer immunology and colorectal cancer recurrence" . . "1"^^ . "189111" . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . "Cancer immunology and colorectal cancer recurrence" . . . . "Cancer immunology and colorectal cancer recurrence"@en . "-" . "1"^^ . "RIV/61388971:_____/11:00375273!RIV12-AV0-61388971" . "3" . "Cancer immunology and colorectal cancer recurrence"@en . . . "P(IAA500200917), Z(AV0Z50200510)" . "1945-0524" . "[DFAD8F9E43A8]" . "RIV/61388971:_____/11:00375273" . . "11"^^ . . . "Vannucci, Luca" . . "-" . . "The recurrence of a cancer - local or distant (metastasis) - is manifested by the persistence of cancer cells in the organism after the ablation of the primary lesion, an ineffective anticancer immune response, and by the activity of biological/immunological factors that can stimulate and sustain its development. This review focuses on colorectal carcinoma and discusses some aspects of cancer immunology regarding cancer development and its recurrence. It is addressed also to the clinician to provide new insights helpful for designing better therapeutic strategies and patient's follow up. Therapeutic approaches used during and after surgical treatments, found capable of modulating immunity (differently affecting disease outcome), will also be described" .